ConductScience.org, home

Paper37397366

Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.

Torres-Sanchez A and 5 others. Front Oncol, 2023. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models. Papers, record 37397366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37397366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2024-07-06
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Torres-Sanchez AAnamaris
2Rivera-Robles MMichael
3Castillo-Pichardo LLinette
4Martínez-Ferrer MMagaly
5Dorta-Estremera SMStephanie M
6Dharmawardhane SSuranganie

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P20 GM103475NIGMS NIH HHSUnited StatesP20GM103475PubMed and NIHNIH RePORTER
R25 GM061838NIGMS NIH HHSUnited StatesR25GM061838PubMedNIH RePORTER
R16 GM149427NIGMS NIH HHSUnited StatesR16GM149427PubMed and NIHNIH RePORTER
R25 GM061151NIGMS NIH HHSUnited StatesR25GM061151PubMedNIH RePORTER
SC3 GM084824NIGMS NIH HHSUnited StatesSC3GM084824PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06075810A Study of Oral MBQ-167 in Participants With Advanced Breast CancerBackground

Source ClinicalTrials.gov

Download CSV of trials

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19050374Rho GTPases and leukocyte cytoskeletal regulation.Curr Opin Hematol1997https://conductscience.org/library/papers/9050374PubMed
228807941The Rac GTPase in Cancer: From Old Concepts to New Paradigms.Cancer Res2017https://conductscience.org/library/papers/28807941PubMed
325389450The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.Transl Oncol2014https://conductscience.org/library/papers/25389450PubMed
434607932Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.Mol Cancer Ther2021https://conductscience.org/library/papers/34607932PubMed
529976575IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.Cancer Res2018https://conductscience.org/library/papers/29976575PubMed
627376091Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes.J Immunol Res2016https://conductscience.org/library/papers/27376091PubMed
735537412Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.Cancer Cell2022https://conductscience.org/library/papers/35537412PubMed
832445205Macrophage targeting in cancer.Ann N Y Acad Sci2021https://conductscience.org/library/papers/32445205PubMed
921965337Breast cancer stem cells, cytokine networks, and the tumor microenvironment.J Clin Invest2011https://conductscience.org/library/papers/21965337PubMed
1024875653Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.J Natl Cancer Inst2014https://conductscience.org/library/papers/24875653PubMed
1131629410Tumor-associated macrophages: an accomplice in solid tumor progression.J Biomed Sci2019https://conductscience.org/library/papers/31629410PubMed
1230065108The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic.Biochem Soc Trans2018https://conductscience.org/library/papers/30065108PubMed
1331043378Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.Cancer Res2019https://conductscience.org/library/papers/31043378PubMed
1431720502Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography-Tandem Mass Spectrometry.ACS Omega2019https://conductscience.org/library/papers/31720502PubMed
1531053634Defining the Hallmarks of Metastasis.Cancer Res2019https://conductscience.org/library/papers/31053634PubMed
1626253167M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.BMC Cancer2015https://conductscience.org/library/papers/26253167PubMed
1724613573The IL-6 feed-forward loop: a driver of tumorigenesis.Semin Immunol2014https://conductscience.org/library/papers/24613573PubMed
1833365025Tumor-Associated Macrophages in Tumor Immunity.Front Immunol2020https://conductscience.org/library/papers/33365025PubMed
1929481824Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3.Immunol Lett2018https://conductscience.org/library/papers/29481824PubMed
2028212753The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.Mol Cell2017https://conductscience.org/library/papers/28212753PubMed

See all 61 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42856377Chemical proteomics reveals post-translational remodeling of endosomal pathways during macrophage activation.bioRxiv2026https://conductscience.org/library/papers/42856377PubMed
42520352Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment.Cancer Treat Res Commun2026https://conductscience.org/library/papers/42520352PubMed
41663524Peripheral blood CD14 + monocytes in luminal breast carcinoma subtypes: in preliminary research and overview of candidate biomarker proteins.Sci Rep2026https://conductscience.org/library/papers/41663524PubMed
40723284Cancer-Associated Fibroblasts Establish Spatially Distinct Prognostic Niches in Subcutaneous Colorectal Cancer Mouse Model.Cancers (Basel)2025https://conductscience.org/library/papers/40723284PubMed
40689767Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.FASEB J2025https://conductscience.org/library/papers/40689767PubMed
39104525Understanding tissue-resident macrophages unlocks the potential for novel combinatorial strategies in breast cancer.Front Immunol2024https://conductscience.org/library/papers/39104525PubMed
39087451Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.Mol Cancer Ther2024https://conductscience.org/library/papers/39087451PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37397366

GET https://conductscience.org/api/papers/v1/37397366/references?page=2